Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
338.86
+0.60 (0.18%)
Feb 12, 2026, 2:47 PM EST - Market open
Penumbra Employees
Penumbra had 4,500 employees as of December 31, 2024. The number of employees increased by 300 or 7.14% compared to the previous year.
Employees
4,500
Change (1Y)
300
Growth (1Y)
7.14%
Revenue / Employee
$296,400
Profits / Employee
$36,450
Market Cap
13.27B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 4,500 | 300 | 7.14% |
| Dec 31, 2023 | 4,200 | 300 | 7.69% |
| Dec 31, 2022 | 3,900 | 100 | 2.63% |
| Dec 31, 2021 | 3,800 | 500 | 15.15% |
| Dec 31, 2020 | 3,300 | 600 | 22.22% |
| Dec 31, 2019 | 2,700 | 500 | 22.73% |
| Dec 31, 2018 | 2,200 | 500 | 29.41% |
| Dec 31, 2017 | 1,700 | 200 | 13.33% |
| Dec 31, 2016 | 1,500 | 400 | 36.36% |
| Dec 31, 2015 | 1,100 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| Bruker | 11,396 |
| DexCom | 10,300 |
| Bio-Rad Laboratories | 7,700 |
| Bio-Rad Laboratories | 7,700 |
| Globus Medical | 5,300 |
PEN News
- 8 days ago - Boston Scientific announces results for fourth quarter and full year 2025 - PRNewsWire
- 16 days ago - Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 20 days ago - Artisan Small Cap Fund Q4 2025 Portfolio Activity - Seeking Alpha
- 4 weeks ago - Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach - Invezz
- 4 weeks ago - Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. - Barrons
- 4 weeks ago - Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments - Market Watch
- 4 weeks ago - Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock - WSJ
- 4 weeks ago - Boston Scientific to buy Penumbra in deal valued at $14.5 billion - Reuters